ASH: VTE Prophylaxis Uncommon in At-Risk Patients (CME/CE)
NEW ORLEANSOnly a third of hospitalized medical patients at risk of venous thromboembolism (VTE) received prophylaxis, which lasted only three days when it was given, a retrospective review of a large claims databases showed.
source : www.medpagetoday.com
Related News:
- Tight BP Control Flops for Most CKD Patients
- Liver Cells Created From Patients’ Skin Cells
- Genetic Variations Associated With Development Of End-Stage Kidney Disease In Chinese Patients With Diabetes
- Biosynthetic Corneas Restore Sight In Patients With Significant Vision Loss
- Memantine Helps Lewy-Body Dementia Patients — Slightly
- Difficulty swallowing a sign of poor prognosis among hospitalized patients
- Smoking Cessation Benefits MI Patients With Heart Damage
- Body Weight May Affect Glaucoma Risk; New Retinal "Map" May Help Severely Nearsighted Patients
- FDA Approves Longer Use Of Valcyte® For Adult Kidney Transplant Patients At High Risk Of Developing Cytomegalovirus (CMV) Disease
- Older Patients’ Share of Office Visits Grows
Details :
Submited at Sunday, December 6th, 2009 at 7:00 pm on Cardiology by madison
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















